Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Shire
Company Monitoring Page for Shire
latest headlines for company on cafepharma
Shire Secures FDA Approval for HAE Drug Lanadelumab
BioSpace
Fri, 08/24/18 - 11:23 am
Tags:
Shire
,
Takeda
,
HAE
,
hereditary angiodema
,
Takhzyro
,
lanadelumab
,
FDA
Shire, Shionogi File NDA for Intuniv for Adults in Japan
Yahoo/Zacks.com
Mon, 08/13/18 - 05:52 pm
Tags:
Shire
,
Shionogi
,
ADHD
,
Japan
,
Intuniv
Takeda announces new series of non-core-asset sales
GoinPharma
Fri, 08/3/18 - 09:48 am
Tags:
Takeda
,
Shire
,
M&A
Top 10: Takeda’s late-stage pipeline will rely heavily on Shire drugs — but is it worth $62B?
Endpoints
Tue, 07/31/18 - 10:55 pm
Tags:
Takeda
,
Shire
,
M&A
Hoping to shake Allergan/Shire’s dry eye dominance, Oyster Point posts positive Phase IIb data for rival drug
Endpoints
Thu, 07/12/18 - 11:49 am
Tags:
Oyster Point
,
OC-02
,
dry eye disease
,
Allergan
,
Restasis
,
Shire
,
Xiidra
FTC Clears Takeda's Acquisition of Shire
CP Wire
Tue, 07/10/18 - 11:46 am
Tags:
FTC
,
M&A
,
Takeda
,
Shire
More than $100 Billion Spent on M&A in the First 6 Months of 2018
BioSpace
Thu, 07/5/18 - 10:28 pm
Tags:
M&A
,
biotech
,
Celgene
,
Sanofi
,
Impact Biomedicines
,
Bioverativ
,
GSK
,
Takeda
,
Shire
,
JNJ
Takeda posts ‘for-sale’ sign on company’s ancestral home in Osaka in effort to fund Shire buyout
Endpoints
Thu, 07/5/18 - 10:50 am
Tags:
Takeda
,
Shire
,
M&A
,
Japan
Takeda shareholders bin proposal from anti-Shire group; only 10 percent in favor
Reuters
Thu, 06/28/18 - 07:15 pm
Tags:
Takeda
,
Shire
,
M&A
,
shareholders
Shire scores new FDA thumbs-up for HAE drug Cinryze in latest bid to fend off rival CSL
Fierce Pharma
Thu, 06/21/18 - 12:02 pm
Tags:
CSL
,
HAE
,
Shire
,
Cinryze
,
Haegarda
Bitterly opposed old guard at Takeda wages a last-ditch fight to block ‘foreign blood’s’ $62B Shire buyout
Endpoints
Mon, 06/11/18 - 09:46 am
Tags:
Takeda
,
Shire
,
Christophe Weber
,
M&A
Takeda shareholders fear dilution, debt from Shire deal pose ‘high risks,’ demand shareholders vote on it
Fierce Pharma
Tue, 05/29/18 - 11:40 am
Tags:
Takeda
,
Shire
,
shareholders
,
M&A
Kickback Allegation Settlements Pile Up for Pharmaceutical Companies
RAPS.org
Sat, 05/26/18 - 09:19 am
Tags:
kickbacks
,
Medicare
,
physicians
,
Pfizer
,
Jazz Pharmaceuticals
,
Valeant Pharmaceuticals
,
Shire
,
Omnicare
Takeda makes $280M divestiture amid Shire buy
Biopharma Dive
Tue, 05/22/18 - 06:41 pm
Tags:
Takeda
,
Shire
,
M&A
,
Guangdong Techpool Bio-Pharma
Takeda CEO Sees Path to Survival in Shire Megadeal
Bloomberg
Thu, 05/17/18 - 10:25 pm
Tags:
Takeda
,
Shire
,
M&A
,
Pharma CEOs
,
Chris Weber
Will Shire’s top R&D talent bolt now that Takeda has struck a merger agreement?
Endpoints
Thu, 05/17/18 - 11:57 am
Tags:
Shire
,
Takeda
,
M&A
,
R&D
Takeda and Shire: A Pricey Marriage
Motley Fool
Mon, 05/14/18 - 11:22 pm
Tags:
Takeda
,
Shire
,
M&A
Whisky, secrets, and code names: behind-the-scenes of Takeda’s $62B Shire bid – Bloomberg
Endpoints
Fri, 05/11/18 - 10:35 am
Tags:
Takeda
,
Shire
,
M&A
Takeda to cut IT, marketing and sales jobs after Shire merger
Pharmaforum
Thu, 05/10/18 - 11:18 pm
Tags:
Takeda
,
Shire
,
M&A
,
layoffs
Takeda Finally Inks a Deal to Buy Shire in One of the Biggest Pharma Takeovers Ever
Fortune
Tue, 05/8/18 - 09:48 am
Tags:
Takeda
,
Shire
,
M&A
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.